XML 94 R80.htm IDEA: XBRL DOCUMENT
v3.7.0.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Apr. 01, 2017 USD ($) | Dec. 31, 2016 USD ($) | Oct. 01, 2016 USD ($) | Jul. 02, 2016 USD ($) | Apr. 02, 2016 USD ($) | Dec. 26, 2015 USD ($) | Sep. 26, 2015 USD ($) | Jun. 27, 2015 USD ($) | Apr. 01, 2017 USD ($) unit | Apr. 02, 2016 USD ($) | Mar. 28, 2015 USD ($)
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of business units | unit |  |  |  |  |  |  |  |  | 4 |  |
Net revenues before foreign exchange impact |  |  |  |  |  |  |  |  | $ 899,580,000 | $ 910,515,000 | $ 883,832,000
Effect of exchange rates |  |  |  |  |  |  |  |  | (13,464,000) | (1,683,000) | 26,541,000
Net revenues | $ 228,066,000 | $ 227,841,000 | $ 220,253,000 | $ 209,956,000 | $ 242,342,000 | $ 233,384,000 | $ 219,693,000 | $ 213,413,000 | 886,116,000 | 908,832,000 | 910,373,000
Segment operating income |  |  |  |  |  |  |  |  | 296,560,000 | 315,230,000 | 317,507,000
Corporate operating expenses |  |  |  |  |  |  |  |  | 176,372,000 | 199,072,000 | 193,910,000
Effect of exchange rates |  |  |  |  |  |  |  |  | (4,772,000) | 3,546,000 | 13,906,000
Restructuring and turnaround costs |  |  |  |  |  |  |  |  | 34,337,000 | 42,185,000 | 69,697,000
Deal amortization |  |  |  |  |  |  |  |  | 27,107,000 | 28,958,000 | 30,184,000
Impairment of assets |  |  |  |  |  |  |  |  | 73,353,000 | 97,230,000 | 0
Contingent consideration income |  |  |  |  |  |  |  |  | 0 | (4,727,000) | (2,918,000)
Operating (loss) income | (57,506,000) | $ 21,212,000 | $ 24,794,000 | $ (7,881,000) | (5,550,000) | $ (61,177,000) | $ 19,179,000 | $ 3,606,000 | (19,381,000) | (43,942,000) | 40,540,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 89,733,000 | 89,911,000 | 86,053,000
Long-lived assets | 323,862,000 |  |  |  | 337,634,000 |  |  |  | 323,862,000 | 337,634,000 | 321,948,000
Plasma [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 410,727,000 | 381,776,000 | 352,911,000
Blood center disposables |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 303,890,000 | 355,108,000 | 386,147,000
Cell Processing [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 105,376,000 | 112,483,000 | 120,434,000
Hemostasis Management [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 66,123,000 | 59,465,000 | 50,881,000
United States |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 522,686,000 | 519,440,000 | 494,788,000
Long-lived assets | 241,610,000 |  |  |  | 231,744,000 |  |  |  | 241,610,000 | 231,744,000 | 208,439,000
Japan |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 79,266,000 | 81,411,000 | 88,298,000
Long-lived assets | 1,691,000 |  |  |  | 2,022,000 |  |  |  | 1,691,000 | 2,022,000 | 1,618,000
Europe |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 166,007,000 | 187,725,000 | 215,575,000
Long-lived assets | 12,952,000 |  |  |  | 18,672,000 |  |  |  | 12,952,000 | 18,672,000 | 27,786,000
Asia |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 109,858,000 | 111,758,000 | 102,095,000
Long-lived assets | 34,174,000 |  |  |  | 40,235,000 |  |  |  | 34,174,000 | 40,235,000 | 39,032,000
Other |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 8,299,000 | 8,498,000 | 9,617,000
Long-lived assets | 33,435,000 |  |  |  | 44,961,000 |  |  |  | 33,435,000 | 44,961,000 | 45,073,000
Japan |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues before foreign exchange impact |  |  |  |  |  |  |  |  | 74,695,000 | 84,270,000 | 83,547,000
Segment operating income |  |  |  |  |  |  |  |  | 32,906,000 | 38,280,000 | 36,843,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 827,000 | 774,000 | 767,000
Long-lived assets | 21,412,000 |  |  |  | 33,159,000 |  |  |  | 21,412,000 | 33,159,000 | 31,810,000
EMEA [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues before foreign exchange impact |  |  |  |  |  |  |  |  | 198,396,000 | 204,192,000 | 219,153,000
Segment operating income |  |  |  |  |  |  |  |  | 49,105,000 | 47,168,000 | 60,101,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 4,255,000 | 5,146,000 | 5,045,000
Long-lived assets | 63,854,000 |  |  |  | 63,861,000 |  |  |  | 63,854,000 | 63,861,000 | 66,223,000
North America Plasma [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues before foreign exchange impact |  |  |  |  |  |  |  |  | 309,718,000 | 279,803,000 | 240,705,000
Segment operating income |  |  |  |  |  |  |  |  | 105,253,000 | 109,220,000 | 89,092,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 13,022,000 | 12,944,000 | 11,229,000
Long-lived assets | 142,164,000 |  |  |  | 116,001,000 |  |  |  | 142,164,000 | 116,001,000 | 101,272,000
All Other |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues before foreign exchange impact |  |  |  |  |  |  |  |  | 316,771,000 | 342,249,000 | 340,427,000
Segment operating income |  |  |  |  |  |  |  |  | 109,296,000 | 120,562,000 | 131,471,000
Depreciation and amortization |  |  |  |  |  |  |  |  | 71,629,000 | 71,047,000 | 69,012,000
Long-lived assets | $ 96,432,000 |  |  |  | $ 124,613,000 |  |  |  | $ 96,432,000 | $ 124,613,000 | $ 122,643,000

X
- Definition Asset Impairment, Unallocated Amount + References No definition available. + Details
Name: | hae_AssetImpairmentUnallocatedAmount
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Corporate Operating Expenses (Constant Currency) + References No definition available. + Details
Name: | hae_CorporateOperatingExpensesConstantCurrency
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Net Revenues, Constant Currency + References No definition available. + Details
Name: | hae_NetRevenuesConstantCurrency
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Segment Operating Income (Constant Currency) + References No definition available. + Details
Name: | hae_SegmentOperatingIncomeConstantCurrency
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Unallocated Amounts, Restructuring and Restructuring Related Costs + References No definition available. + Details
Name: | hae_UnallocatedAmountsRestructuringandRestructuringRelatedCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 + Details
Name: | us-gaap_NoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Reporting Unit -URI http://asc.fasb.org/extlink&oid=6523643 + Details
Name: | us-gaap_NumberOfReportingUnits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueGoodsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_CellProcessingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_HemostasisManagementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_NorthAmericaPlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_AmericasBloodCenterandHospitalandAsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |